Research ExplorerScientific StaffElena Laakmann

Dr.med. ID: 33463

Elena Laakmann

graph of relations
Affiliations

Publications

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Detection and Characterization of Estrogen Receptor α Expression of Circulating Tumor Cells as a Prognostic Marker

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (25)